Dechra

Equipalazone 1g Oral Powder for Horses

Price range: £1.05 through £102.00

Equipalazone Oral Powder contains Phenylbutazone (“Bute”) which is a an anti-inflammatory & analgesic (pain relief) drug.

Legal category : POM-V

This product requires a valid veterinary prescription for purchase

Pack size

Flavour

Clear

Prescriptions

I understand a valid veterinary prescription is required for this prescription-only medicine *
I will provide my prescription by: *
Email prescription *

Please e-mail your prescription to [email protected]
Post prescription *

Please send to: Dr Nicola Endersby MRCVS, Cura, 4 Saxon Court, Bishop Auckland DL14 7UA

Vet will send directly *

Please ask your vet to e-mail your prescription to [email protected] with your name and order number as a reference. (You will receive your order number once you have completed your purchase) Please confirm your Vet Practice name below

Your vet practice: *
Prescription *

Please upload your prescription for this product.Max file size: 25 MBPermitted file types: jpg jpeg jpe gif png pdf
Animal name(s) *

Product total

Options total

Grand total

View POM Delivery & Returns

Secure Checkout with

Accredited Retailer

Equipalazone Oral Powder is supplied in sachets. These each contain 1g of Phenylbutazone ("bute"), a drug from the NSAID group (Non Steroidal Anti-inflammatory Drug). Bute is used for the treatment of lameness in horses, eg acute & chronic laminiti, osteoarthritic conditions, bursitis & carpitis.
It can also be used post-surgery to relieve soft tissue swelling.
Bute is also antipyretic (lowers fevers). It works by inhibiting the body from synthesising prostaglandins, which facilitate pain & trigger inflammatory processes & pyrogens (substances which cause a fever).
Equipalazone is supplied in single sachets or packs of 100.

This product requires a prescription from your vet & will only be dispatched once we receive this prescription.

Legal Category- POM-V

Warnings & Contraindications- Do not give to horses with known hypersensitivity to Phenylbutazone. Do not give to horses with heart, liver or kidney disease; gastric ulceration or blood disorders. Do not give within 24 hours of giving another NSAID or corticosteroid, please contact your vet or our helpline if unsure.
Pregnancy & Lactation- Seek advice from your vet for use during pregnancy & lactation. Use not recommended during first trimester of pregnancy.
Passport Requirements- This medication cannot be used in horses intended for human consumption. Your vet must have signed Section 9 of your horse's passport (or Section 2 for passports issued after 1st January 2016).

Product Description

Equipalazone Oral Powder is supplied in sachets. These each contain 1g of Phenylbutazone (“bute”), a drug from the NSAID group (Non Steroidal Anti-inflammatory Drug). Bute is used for the treatment of lameness in horses, eg acute & chronic laminiti, osteoarthritic conditions, bursitis & carpitis.
It can also be used post-surgery to relieve soft tissue swelling.
Bute is also antipyretic (lowers fevers). It works by inhibiting the body from synthesising prostaglandins, which facilitate pain & trigger inflammatory processes & pyrogens (substances which cause a fever).
Equipalazone is supplied in single sachets or packs of 100.

This product requires a prescription from your vet & will only be dispatched once we receive this prescription.

Legal Category- POM-V

Warnings & Contraindications- Do not give to horses with known hypersensitivity to Phenylbutazone. Do not give to horses with heart, liver or kidney disease; gastric ulceration or blood disorders. Do not give within 24 hours of giving another NSAID or corticosteroid, please contact your vet or our helpline if unsure.
Pregnancy & Lactation- Seek advice from your vet for use during pregnancy & lactation. Use not recommended during first trimester of pregnancy.
Passport Requirements- This medication cannot be used in horses intended for human consumption. Your vet must have signed Section 9 of your horse’s passport (or Section 2 for passports issued after 1st January 2016).